Aadi Bioscience (AADI) Competitors $1.68 -0.03 (-1.75%) As of 04/15/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AADI vs. DBVT, IPHA, FULC, NBTX, ACTU, MOLN, RZLT, ACIU, TARA, and DMACShould you be buying Aadi Bioscience stock or one of its competitors? The main competitors of Aadi Bioscience include DBV Technologies (DBVT), Innate Pharma (IPHA), Fulcrum Therapeutics (FULC), Nanobiotix (NBTX), Actuate Therapeutics (ACTU), Molecular Partners (MOLN), Rezolute (RZLT), AC Immune (ACIU), Protara Therapeutics (TARA), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. Aadi Bioscience vs. DBV Technologies Innate Pharma Fulcrum Therapeutics Nanobiotix Actuate Therapeutics Molecular Partners Rezolute AC Immune Protara Therapeutics DiaMedica Therapeutics Aadi Bioscience (NASDAQ:AADI) and DBV Technologies (NASDAQ:DBVT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, community ranking, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings. Do analysts recommend AADI or DBVT? Aadi Bioscience currently has a consensus price target of $1.67, indicating a potential downside of 0.79%. DBV Technologies has a consensus price target of $22.50, indicating a potential upside of 184.45%. Given DBV Technologies' stronger consensus rating and higher probable upside, analysts plainly believe DBV Technologies is more favorable than Aadi Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00DBV Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, AADI or DBVT? Aadi Bioscience has higher revenue and earnings than DBV Technologies. DBV Technologies is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAadi Bioscience$25.07M1.66-$65.76M-$2.35-0.71DBV Technologies$15.73M10.34-$72.73M-$5.00-1.58 Is AADI or DBVT more profitable? Aadi Bioscience has a net margin of -246.06% compared to DBV Technologies' net margin of -815.73%. Aadi Bioscience's return on equity of -71.87% beat DBV Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Aadi Bioscience-246.06% -71.87% -57.28% DBV Technologies -815.73%-106.07%-76.17% Do institutionals & insiders believe in AADI or DBVT? 52.1% of Aadi Bioscience shares are owned by institutional investors. Comparatively, 71.7% of DBV Technologies shares are owned by institutional investors. 37.3% of Aadi Bioscience shares are owned by insiders. Comparatively, 1.9% of DBV Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer AADI or DBVT? DBV Technologies received 394 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 54.22% of users gave DBV Technologies an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformAadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% DBV TechnologiesOutperform Votes40554.22% Underperform Votes34245.78% Does the media refer more to AADI or DBVT? In the previous week, DBV Technologies had 7 more articles in the media than Aadi Bioscience. MarketBeat recorded 7 mentions for DBV Technologies and 0 mentions for Aadi Bioscience. DBV Technologies' average media sentiment score of 0.03 beat Aadi Bioscience's score of 0.00 indicating that DBV Technologies is being referred to more favorably in the news media. Company Overall Sentiment Aadi Bioscience Neutral DBV Technologies Neutral Which has more volatility & risk, AADI or DBVT? Aadi Bioscience has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, DBV Technologies has a beta of -0.08, indicating that its share price is 108% less volatile than the S&P 500. SummaryAadi Bioscience and DBV Technologies tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AADI vs. The Competition Export to ExcelMetricAadi BiosciencePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.63M$6.26B$5.29B$7.35BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-0.746.6921.6517.68Price / Sales1.66222.70371.0992.89Price / CashN/A65.6738.1534.64Price / Book0.395.776.373.94Net Income-$65.76M$142.01M$3.20B$247.45M7 Day Performance6.33%2.88%1.79%0.48%1 Month Performance-15.15%-13.93%-9.41%-7.08%1 Year Performance-6.15%-12.36%9.61%-0.35% Aadi Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AADIAadi BioscienceN/A$1.68-1.8%$1.67-0.8%-10.0%$50.63M$25.07M-0.7440Gap DownDBVTDBV Technologies2.6126 of 5 stars$7.79+6.4%$22.50+188.8%+5.7%$160.23M$15.73M-1.7380Earnings ReportAnalyst ForecastShort Interest ↑IPHAInnate Pharma2.4818 of 5 stars$1.90+1.3%$11.50+505.3%-21.1%$159.28M$12.63M0.00220News CoveragePositive NewsGap UpFULCFulcrum Therapeutics2.1565 of 5 stars$2.92+8.6%$8.63+195.4%-58.7%$157.62M$80M-9.42100Short Interest ↓Positive NewsGap DownNBTXNanobiotix2.1389 of 5 stars$3.33flat$8.00+140.2%-39.1%$156.95M$-11,609,000.000.00100ACTUActuate TherapeuticsN/A$8.00+4.4%$20.00+150.0%N/A$156.26MN/A0.0010MOLNMolecular Partners2.0878 of 5 stars$3.86-0.3%$12.00+210.9%-4.9%$155.85M$4.97M-1.80180Upcoming EarningsNews CoverageRZLTRezolute2.8691 of 5 stars$2.57+4.0%$24.38+848.4%-14.9%$155.58MN/A-2.1140Positive NewsGap DownACIUAC Immune2.505 of 5 stars$1.52-2.6%$12.00+689.5%-40.1%$152.62M$27.31M-3.30140Analyst RevisionGap DownTARAProtara Therapeutics2.0006 of 5 stars$4.14+5.9%$22.50+443.5%+46.8%$152.22MN/A-1.4730Analyst ForecastNews CoveragePositive NewsDMACDiaMedica Therapeutics1.2195 of 5 stars$3.54+2.0%$8.00+126.0%+46.9%$151.71MN/A-6.3220Short Interest ↑Gap Up Remove Ads Related Companies and Tools Related Companies DBVT Competitors IPHA Competitors FULC Competitors NBTX Competitors ACTU Competitors MOLN Competitors RZLT Competitors ACIU Competitors TARA Competitors DMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AADI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredFBI Warns: Wave Of Retiree Cyber Hacks Coming In 2025Try to think back to the fall of 2008… The pandemic accelerated America's descent into a “no-cash society” ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AADI Stock Free AADI Stock Alerts